Study on HHV8 Infection and Multiple Myeloma Risk
Author Information
Author(s): Tedeschi R, Kvarnung M, Knekt P, Schulz T F, Szekely L, Paoli P De, Aromaa A, Teppo L, Dillner J
Primary Institution: Centro di Riferimento Oncologico-Istituto Nazionale Tumori, Aviano, Italy
Hypothesis
Is HHV8 infection associated with an increased risk of multiple myeloma?
Conclusion
The study found no statistically significant evidence linking HHV8 infection to the risk of developing multiple myeloma.
Supporting Evidence
- HHV8 seropositivity for at least one HHV8 protein was found in 7% of the Finnish population.
- No association was found between HHV8 seropositivity and the risk of developing multiple myeloma.
- HHV8 seropositivity for lytic antigens was found in 16% of the population.
- HHV8 seropositivity for latent antigens was found in 0.4% of the population.
Takeaway
The study looked at whether a virus called HHV8 could make people more likely to get a type of blood cancer called multiple myeloma, but it didn't find any strong evidence that it does.
Methodology
The study evaluated serum samples from 39,000 Finnish subjects, comparing those who developed multiple myeloma with matched healthy subjects.
Limitations
The study's findings may be limited by the small number of cases of multiple myeloma and the potential for confounding factors.
Participant Demographics
Finnish population, with serum samples collected from 1968 to 1972.
Statistical Information
Confidence Interval
CI: 0.25–3.25 for HHV8 seropositivity on WB; CI: 0.94–4.33 and CI: 0.91–110.29 for IFA.
Statistical Significance
p>0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website